FIBROSIS
Clinical trials for FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new FIBROSIS trials appear
Sign up with your email to follow new studies for FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to ease lung pressure in scarred lungs
Disease control Recruiting nowThis study tests whether adding a new inhaled drug, mosliciguat, to an existing treatment (treprostinil) is safe for people with high blood pressure in the lungs caused by lung scarring. About 20 adults with this condition will receive the combination and be monitored for side ef…
Matched conditions: FIBROSIS
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated May 17, 2026 08:51 UTC
-
Repurposed drugs may stop radiation side effects
Disease control Recruiting nowThis study tests whether two existing drugs—pentoxifylline with vitamin E, or pravastatin—can prevent or reduce lymphedema and fibrosis (tissue hardening) caused by radiation therapy for head and neck cancer. About 295 adults will receive one of these treatments alongside standar…
Matched conditions: FIBROSIS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 08:50 UTC
-
Copper pills may boost liver health in cirrhosis patients
Disease control Recruiting nowThis study tests whether giving copper supplements to people with cirrhosis (scarred liver) and low copper levels can improve liver function and reduce infections. About 30 adults with cirrhosis and low blood copper will receive either copper or a placebo for several weeks, then …
Matched conditions: FIBROSIS
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New hope for cancer survivors: drug trial targets radiation damage
Disease control Recruiting nowThis study tests if adding medication can treat or prevent lymphedema and fibrosis (tissue hardening and swelling) caused by radiation therapy in head and neck cancer survivors. Researchers will compare different drugs to find the most effective one. The trial involves 250 partic…
Matched conditions: FIBROSIS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 04, 2026 16:30 UTC
-
Spa treatment may ease radiation skin damage in cancer survivors
Symptom relief Recruiting nowThis study tests whether a special spa therapy program can improve skin-related quality of life for people who have skin hardening or scarring (fibrosis) after radiation for breast or head/neck cancer. About 110 adults who finished radiation at least 6 months ago will be randomly…
Matched conditions: FIBROSIS
Phase: NA • Sponsor: Association Francaise pour la Recherche Thermale • Aim: Symptom relief
Last updated May 08, 2026 12:03 UTC
-
HIV drug showdown: which is safer for your liver?
Knowledge-focused Recruiting nowThis study looks at 200 people with HIV to see if two types of HIV drugs (NNRTI and INSTI) cause different amounts of fat buildup or scarring in the liver. Participants will have ultrasound and other scans to measure liver health. The goal is to understand which drug might be saf…
Matched conditions: FIBROSIS
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 08:51 UTC
-
Diaphragm dysfunction may explain shortness of breath in lung patients
Knowledge-focused Recruiting nowThis study looks at how well the diaphragm works in 800 people with lung diseases like asthma, COPD, fibrosis, and pulmonary hypertension. Researchers want to see if diaphragm problems are linked to shortness of breath. Participants will do walking and sitting tests to measure br…
Matched conditions: FIBROSIS
Sponsor: RWTH Aachen University • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC